CBL-0137 | m-entrepreneurship.com

Product Name :
CBL-0137

Search keywords :
CBL0137

drugId :
null

Target Vo:
Nuclear factor NF-kappa-B complex

Target Vo Short Name :
NF-κB

Moa_Name:
Tumor protein p53 stimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Cleveland Biolabs Inc

Active Company_Name :
Incuron LLC

Active Indication_Name:
Osteosarcoma

In Active Indication_Name:
Melanoma

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Anifrolumab Autophagy
JAK1 Rabbit mAb MedChemExpress
PRMT1 Antibody (YA686): PRMT1 Antibody (YA686) is a non-conjugated and Mouse origined monoclonal antibody about 42 kDa, targeting to PRMT1 (4E9). It can be used for WB assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts